Business Description
Taysha Gene Therapies is a Dallas-based biotech company working to develop gene therapies for rare and serious brain and nervous system disorders caused by single gene defects. Founded in 2019, the company has a pipeline of treatments targeting conditions such as Rett syndrome, giant axonal neuropathy, and fragile X syndrome, among others. Taysha works in partnership with the University of Texas Southwestern Medical Center to advance its research.
